FindTrial
Sign In

Leucocyte-reduced platelet-rich plasma in the treatment of knee osteoarthritis: a randomized, double-blinded, controlled trial

Leucocyte-reduced platelet-rich plasma in the treatment of knee osteoarthritis: a randomized, double-blinded, controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017946
Enrollment
Unknown
Registered
2018-08-24
Start date
2019-05-01
Completion date
Unknown
Last updated
2018-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Interventions

Leucocyte-reduced PRP:Intra-articular injections of Leucocyte-reduced PRP
Leucocyte- and platelet-rich plasma:Intra-articular injections of Leucocyte-rich PRP
hyaluronic acid:Intra-articular injections ofhyaluronic acid

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with knee osteoarthritis

Exclusion criteria

Exclusion criteria: 1. patient age less than 18 years old; 2. history of knee operations; 3. history of knee intra-articular injections or oral NASID in the past 6 months; 4. Unable to receive pre-treatment assessment and post-treatment follow-up; 5. patients with blood diseases.

Design outcomes

Primary

MeasureTime frame
WOMAC scores;—

Countries

China

Contacts

Public ContactXIE XUETAO

Shanghai Sixth People's Hospital

xuetaoxie@163.com+86 18930170231

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026